Ontology highlight
ABSTRACT:
SUBMITTER: Li X
PROVIDER: S-EPMC6000013 | biostudies-other | 2014 Apr
REPOSITORIES: biostudies-other
Zhongguo fei ai za zhi = Chinese journal of lung cancer 20140401 4
Lung cancer is one of the most common malignant tumor in the world, severely threatening human life. Recently, targeted therapy such as the epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) made huge progress in treatment of lung cancer. EGFR-TKIs, with its high selectivity and low toxicity, is the first choice for EGFR-mutated patients in stage IV non-small cell lung cancer (NSCLC). However, secondary drug resistance becomes a clinical problem to be urgently resolved. In r ...[more]